Previous findings have described IL-7 as fundamental for the activation of myeloid cell populations in mice bearing CT26 tumors (38) and for tumor invasiveness in prostate cancer (39), while IL-15–dependent signaling in tumor-associated macrophages inhibited CD8+ T cell recruitment in breast cancer (40). The gene discussed is IL7; the disease is prostate carcinoma.